277 related articles for article (PubMed ID: 30337054)
1. Tacrolimus, not triamcinolone acetonide, interacts synergistically with itraconazole, terbinafine, bifonazole, and amorolfine against clinical dermatophyte isolates.
Zhang J; Tan J; Yang L; He Y
J Mycol Med; 2018 Dec; 28(4):612-616. PubMed ID: 30337054
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
[TBL] [Abstract][Full Text] [Related]
3. Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.
Bhatia VK; Sharma PC
Indian J Med Microbiol; 2015; 33(4):533-7. PubMed ID: 26470960
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.
Gupta AK; Kohli Y
Br J Dermatol; 2003 Aug; 149(2):296-305. PubMed ID: 12932235
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of antifungal susceptibility and keratinase, elastase, lipase and DNase activities of different dermatophyte species isolated from clinical specimens in Iran.
Sharifzadeh A; Shokri H; Khosravi AR
Mycoses; 2016 Nov; 59(11):710-719. PubMed ID: 27291045
[TBL] [Abstract][Full Text] [Related]
6. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
Yenişehirli G; Tunçoğlu E; Yenişehirli A; Bulut Y
Int J Dermatol; 2013 Dec; 52(12):1557-60. PubMed ID: 24134487
[TBL] [Abstract][Full Text] [Related]
7. [In vitro antifungal activity of ravuconazole against isolates of dermatophytes and Candida species from patients with dermatomycoses].
Yamaguchi H; Ikeda F; Iyoda T; Suzuki M; Mikawa T
Med Mycol J; 2014; 55(4):J157-63. PubMed ID: 25742996
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes.
Simonetti O; Silvestri C; Arzeni D; Cirioni O; Kamysz W; Conte I; Staffolani S; Orsetti E; Morciano A; Castelli P; Scalise A; Kamysz E; Offidani AM; Giacometti A; Barchiesi F
Mycoses; 2014 Apr; 57(4):233-9. PubMed ID: 26058322
[TBL] [Abstract][Full Text] [Related]
9. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
[TBL] [Abstract][Full Text] [Related]
10. Sertaconazole antifungal profile determined by a microdilution method versus nine topical substances against dermatophyte fungi.
Carrillo-Muñoz AJ; Tur-Tur C; Cárdenes D; Rojas F; Giusiano G
Chemotherapy; 2012; 58(5):399-404. PubMed ID: 23296325
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility of clinically important dermatophytes against statins and different statin-antifungal combinations.
Nyilasi I; Kocsubé S; Krizsán K; Galgóczy L; Papp T; Pesti M; Nagy K; Vágvölgyi C
Med Mycol; 2014 Feb; 52(2):140-8. PubMed ID: 24004389
[TBL] [Abstract][Full Text] [Related]
12. Development of an agar-based screening method for terbinafine, itraconazole, and amorolfine susceptibility testing of
Siopi M; Efstathiou I; Arendrup MC; Meletiadis J
J Clin Microbiol; 2024 Jan; 62(1):e0130823. PubMed ID: 38117081
[TBL] [Abstract][Full Text] [Related]
13.
Ansari S; Ahmadi B; Norouzi M; Ansari Z; Afsarian MH; Lotfali E; Rezaei-Matehkolaei A
J Med Microbiol; 2019 Nov; 68(11):1655-1663. PubMed ID: 31573466
[No Abstract] [Full Text] [Related]
14. In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Gupta AK; Kohli Y; Batra R
Med Mycol; 2005 Mar; 43(2):179-85. PubMed ID: 15832561
[TBL] [Abstract][Full Text] [Related]
15. [In vitro antifungal activities of amorolfine against fresh isolates from patients with cutaneous mycosis].
Uchida K; Aoki K; Yamaguchi H
Jpn J Antibiot; 1991 Sep; 44(9):1007-12. PubMed ID: 1960850
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization and antifungal susceptibility profile of dermatophytes isolated from scalp dermatophyte carriage in primary school children in Arak city, Center of Iran.
Allahdadi M; Hajihossein R; Kord M; Rahmati E; Amanloo S; Didehdar M
J Mycol Med; 2019 Apr; 29(1):19-23. PubMed ID: 30660447
[TBL] [Abstract][Full Text] [Related]
17.
Rezaei-Matehkolaei A; Khodavaisy S; Alshahni MM; Tamura T; Satoh K; Abastabar M; Shokoohi GR; Ahmadi B; Kord M; Taghipour S; Makimura K; Badali H
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530856
[TBL] [Abstract][Full Text] [Related]
18. In vitro antifungal activity of sertaconazole against 309 dermatophyte clinical isolates.
Carrillo-Muñoz AJ; Fernandez-Torres B; Guarro J
J Chemother; 2003 Dec; 15(6):555-7. PubMed ID: 14998079
[TBL] [Abstract][Full Text] [Related]
19. Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates.
Salehi Z; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1841-1846. PubMed ID: 29980898
[TBL] [Abstract][Full Text] [Related]
20. Comparison of disk diffusion method and broth microdilution method for antifungal susceptibility testing of dermatophytes.
Esteban A; Abarca ML; Cabañes FJ
Med Mycol; 2005 Feb; 43(1):61-6. PubMed ID: 15712608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
